A vaccine for aging that eliminates senescent cells

Latest articles

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

It’s time to reboot longevity and healthy aging

Dr Michael Roizen calls for fundamental societal changes to ensure the benefits of longevity and healthy aging are realised. Later this year, best-selling author Michael...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

Click the globe for translations.

Japanese researchers claim vaccine eliminates senescent cells.

A team of researchers in Japan, led by Professor Toru Minamino of Juntendo University, claims to have developed a vaccine that removes the senescent cells that build up with age; senescence cells, often called zombie cells, emit damaging toxic chemicals and cause several age-related diseases, including arterial stiffening, which was part of the experiment reported in Nature Aging.

Longevity.Technology: Vaccines have been headline news for the last year-and-a-half and with good reason. The world has seen how quickly a vaccine can be developed and rolled out when there is an urgent need. Now is the time for research and big pharma to bend their resources in the direction of vaccines for aging – imagine how many age-related diseases could be ameliorated if we could vaccinate against senescence and the enormous benefit not only for people, but for healthcare systems, the economy and the whole of society.

As Dr David Sinclair tweeted: “Okay, this is a big deal: Vaccinations against aging work. Sure, it’s a proof-of-principle study in a rapidly aging mouse, but there’s little doubt this will be possible in us one day.”

What are zombie cells?

Cellular senescence is one of the hallmarks of aging; when a cell reaches the end of its lifespan, and has stopped dividing and contributing usefully to the metabolic processes involved in being alive, it should die and be recycled. Some cells don’t get the “time to die” memo; instead they hang around, secreting a cocktail of inflammatory chemicals, called senescence-associated secretory phenotype, or SASP, and encouraging otherwise healthy cells to cross over to the dark side.

SASP-produced chemicals adversely affect neighbouring cells, the surrounding extracellular matrix and other structural components, causing a cascade of negative effects which can include chronic inflammation, arthritis and arterial stiffening, as well as triggering senescence in healthy cells.

How does the vaccine work?

The researchers discovered a protein in senescent cells – glycoprotein nonmetastatic melanoma protein B (GPNMB) – that is present in both humans and mice. Using an amino acid in GPNMB, the research team created a peptide vaccine which enabled the body to create antibodies that attach themselves to senescent cells; once attached, leukocytes finished the job by attached to the antibodies and removing the senescent cells.

According to the paper, mice treated with the vaccine demonstrated decreased levels of senescent cells [1] – a vaccine for aging, if you will.

Experimenting with senescence

In the experiment, the researchers treated mice that had arterial stiffening with the vaccine; the results showed that many senescent cells were eliminated and the size of areas afflicted by stiffening became smaller. When the research team used the vaccine on aged mice, their frailty progression was slowed in comparison with unvaccinated mice [1].

Principal investigator Professor Minamino from Juntendo University said: “We can expect that [the vaccine] will be applied to the treatment of arterial stiffening, diabetes and other aging-related diseases [2].”

Senolytic therapies are often effective when tested, but can come with unwelcome or harmful side effects. According to the research team, the new vaccine is associated with fewer side effects and has an added benefit of longer-lasting efficacy [2].

[1] https://www.nature.com/articles/s43587-021-00151-2
[2] https://www.japantimes.co.jp/news/2021/12/12/national/science-health/aging-vaccine

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Sugar-proof your health with the GLYLO weight loss and antiaging supplement

Move your New Year's resolution up a gear with GLYLO, a double-action supplement that can increase weight loss while also slowing aging. Choosing an effective...

Related articles

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

Mental illness drug discovery company Neurai Life Sciences launches

AI will drive discovery of innovative small molecules and next generation therapies to treat mental health disorders. Wuhan, a bioceutical company focused on alternative plant-based...

StarkAge secures 2 million euros for senescence targeting therapy

Funding from Bpifrance's Deeptech program will drive development of company’s immunotherapy approach targeting cellular senescence in age-related disease. French biotech startup StarkAge Therapeutics today announced...

Genflow IPO “starts a new chapter” for longevity biotech

Company floats on London Stock Exchange and becomes Europe’s first publicly traded longevity biotech. Today, Genflow Biosciences became the first longevity biotech IPO of 2022...

Roll up, roll up… it’s the Longevity Biotech Virtual Job Fair!

Amplifying the longevity biotech space with exciting opportunities and brand-new start. The new year brings new opportunities, and the new Longevity Biotech Virtual Job Fair...

    Subscribe to our newsletter